The Chemours Company’s (CC - Free Report) shares have shot up 30.4% over the past three months. The company has also outperformed its industry’s rise of 12.9% to over the same time frame.
Chemours, a Zacks Rank #2 (Buy) stock, has a market cap of roughly $4.4 billion and average volume of shares traded in the last three months is around 1,064.7K.
Let’s delve deeper into the factors behind the stock’s price appreciation.
What’s Favoring CC?
Chemours is gaining from a recovery in demand from the coronavirus-induced slowdown and its cost-reduction measures. It delivered forecast-topping results in the third quarter on the back of demand recovery, cost-cutting actions and strong execution.
In its Fluoroproducts segment, the company is seeing improved customer demand for refrigerants, especially in the automotive sector on a rebound in automotive OEM production rates. It is also witnessing demand recovery in architectural coatings, laminates and plastics markets in its Titanium Technologies segment. The company is seeing a recovery across all markets and regions.
Chemours is also poised to benefit from increasing adoption of the Opteon platform and growing applications of fluoropolymers, especially in automotive, electronics and energy end-markets. The company is seeing higher demand for Opteon in mobile applications. It remains committed to drive Opteon adoption. It is ramping up production at the new low-cost Opteon Corpus Christi facility.
Moreover, the company stands to gain from its efforts to reduce costs. It is taking actions to cut costs by reducing overhead, discretionary spend and capital expenditure for 2020. These actions are helping it to generate strong cash flows. Chemours aims to cut costs by $160 million and capital expenditure by roughly $125 million in 2020. The company’s cost and operational improvement actions across its businesses are expected to support margins in 2020.
The company also has a strong liquidity position. It ended the third quarter with cash and cash equivalents of $956 million and total liquidity of $1.7 billion.
Earnings estimate revisions also have the greatest impact on stock prices. Over the past month, the Zacks Consensus Estimate for Chemours for the current year has increased around 15%. The consensus estimate for 2021 has also been revised 17.1% upward over the same time frame.
Stocks to Consider
Other top-ranked stocks worth considering in the basic materials space include Bunge Limited (BG - Free Report) , Impala Platinum Holdings Limited (IMPUY - Free Report) and BHP Group (BHP - Free Report) .
Bunge has an expected earnings growth rate of 43% for the current year. The company’s shares have gained around 15% in the past year. It currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Impala Platinum has an expected earnings growth rate of 131.7% for the current fiscal. The company’s shares have rallied around 29% in the past year. It currently carries a Zacks Rank #2.
BHP Group has a projected earnings growth rate of 32.4% for the current fiscal year. The company’s shares have gained around 18% in a year. It currently carries a Zacks Rank #2.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.4% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
The Chemours Company’s (CC - Free Report) shares have shot up 30.4% over the past three months. The company has also outperformed its industry’s rise of 12.9% to over the same time frame.
Chemours, a Zacks Rank #2 (Buy) stock, has a market cap of roughly $4.4 billion and average volume of shares traded in the last three months is around 1,064.7K.
Let’s delve deeper into the factors behind the stock’s price appreciation.
What’s Favoring CC?
Chemours is gaining from a recovery in demand from the coronavirus-induced slowdown and its cost-reduction measures. It delivered forecast-topping results in the third quarter on the back of demand recovery, cost-cutting actions and strong execution.
In its Fluoroproducts segment, the company is seeing improved customer demand for refrigerants, especially in the automotive sector on a rebound in automotive OEM production rates. It is also witnessing demand recovery in architectural coatings, laminates and plastics markets in its Titanium Technologies segment. The company is seeing a recovery across all markets and regions.
Chemours is also poised to benefit from increasing adoption of the Opteon platform and growing applications of fluoropolymers, especially in automotive, electronics and energy end-markets. The company is seeing higher demand for Opteon in mobile applications. It remains committed to drive Opteon adoption. It is ramping up production at the new low-cost Opteon Corpus Christi facility.
Moreover, the company stands to gain from its efforts to reduce costs. It is taking actions to cut costs by reducing overhead, discretionary spend and capital expenditure for 2020. These actions are helping it to generate strong cash flows. Chemours aims to cut costs by $160 million and capital expenditure by roughly $125 million in 2020. The company’s cost and operational improvement actions across its businesses are expected to support margins in 2020.
The company also has a strong liquidity position. It ended the third quarter with cash and cash equivalents of $956 million and total liquidity of $1.7 billion.
Earnings estimate revisions also have the greatest impact on stock prices. Over the past month, the Zacks Consensus Estimate for Chemours for the current year has increased around 15%. The consensus estimate for 2021 has also been revised 17.1% upward over the same time frame.
Stocks to Consider
Other top-ranked stocks worth considering in the basic materials space include Bunge Limited (BG - Free Report) , Impala Platinum Holdings Limited (IMPUY - Free Report) and BHP Group (BHP - Free Report) .
Bunge has an expected earnings growth rate of 43% for the current year. The company’s shares have gained around 15% in the past year. It currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Impala Platinum has an expected earnings growth rate of 131.7% for the current fiscal. The company’s shares have rallied around 29% in the past year. It currently carries a Zacks Rank #2.
BHP Group has a projected earnings growth rate of 32.4% for the current fiscal year. The company’s shares have gained around 18% in a year. It currently carries a Zacks Rank #2.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.4% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on BHP - FREE
Get the latest research report on BG - FREE
Get the latest research report on IMPUY - FREE
Get the latest research report on CC - FREE